Skip to main content

Exact Sciences Corp

EXASDelisted
Industry
Services-Medical Laboratories
SEC CIK
0001124140

Exact Sciences Corp was delisted in 2026; its insiders filed their last Form 4 on Mar 23, 2026; 712 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Exact Sciences Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Exact Sciences Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Exact Sciences Corp
NameTitleLast reported holdingLast filingFilings, past year
Coward D ScottDirector0IndirectMar 23, 20261
Orville Jacob AEVP, GM, Screening0IndirectMar 23, 20264
Trigg LeslieDirector0Mar 23, 20261
Conroy Kevin TPresident and CEO0IndirectMar 23, 20264
Popovits Kimberly JDirector0Mar 23, 20261
Zanotti Katherine SDirector0Mar 23, 20262
Clancy Paul JDirector0Mar 23, 20261
Doyle James EdwardDirector0Mar 23, 20262
Petrovic ShaceyDirector0IndirectMar 23, 20261
Condella SarahEVP, Human Resources0IndirectMar 23, 20264
Barber Michael JDirector0Mar 23, 20261
Baranick BrianEVP, GM, Precision Oncology0IndirectMar 23, 20264
Herriott JamesSVP, General Counsel & Sec0IndirectMar 23, 20266
Bloomer AaronEVP, Chief Financial Officer0IndirectMar 23, 20263
Levangie Daniel JDirector34,312Jun 16, 20250
Sebelius KathleenDirector32,671Dec 20, 20240
Cunningham EverettChief Commercial Officer47,042May 2, 20240
Elliott Jeffrey ThomasChief Financial Officer11,795May 2, 20240
Scannell Timothy JDirector5,694Nov 1, 20230
Lewis-Hall Freda CDirector19,688Jun 12, 20230
Jacquet PierreDirector23,576Jun 12, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 21, 2025 (view filing)Nov 192 daysOrville Jacob AEVP, GM, ScreeningSSale−5.00K$75.00−$375.0K−17.7%23.2K after10b5-1
Nov 21, 2025 (view filing)Nov 192 daysHerriott JamesSVP, General Counsel & SecSSale−1.00K$70.00−$70.0K−7.9%11.6K after10b5-1
Nov 6, 2025 (view filing)Nov 42 daysHerriott JamesSVP, General Counsel & SecSSale−1.50K$70.08−$105.1K−10.6%12.6K after10b5-1
Nov 6, 2025 (view filing)Nov 42 daysBaranick BrianEVP, GM, Precision OncologySSale−2.86K$70.08−$200.3K−11.3%22.4K after10b5-1
Oct 27, 2025 (view filing)Oct 243 daysZanotti Katherine SDirectorSSale−12.0K$65.00−$780.0K−16.5%60.8K after10b5-1
Oct 10, 2025 (view filing)Oct 91 dayHerriott JamesSVP, General Counsel & SecSSale−1.50K$60.00−$90.0K−9.6%14.1K after10b5-1
Oct 10, 2025 (view filing)Oct 91 dayDoyle James EdwardDirectorSSale−2.00K$60.00−$120.0K−3.3%58.0K after10b5-1
Aug 14, 2025 (view filing)Aug 131 dayDoyle James EdwardDirectorSSale−1.49K$42.02−$62.4K−2.4%60.0K after10b5-1
Jun 16, 2025 (view filing)Jun 133 daysZanotti Katherine SDirectorSSale−3.21K$53.20−$170.6K−4.2%72.8K after10b5-1
Nov 13, 2024 (view filing)Nov 13Same dayConroy Kevin TPresident and CEOPPurchase+19.5K$51.35+$1.00M+1.8%1.07M after
Oct 9, 2024 (view filing)Oct 81 dayBaranick BrianEVP, GM, Precision OncologySSale−929$70.00−$65.0K−6.8%12.8K after10b5-1
Sep 19, 2024 (view filing)Sep 181 dayBaranick BrianEVP, GM, Precision OncologySSale−929$70.00−$65.0K−6.4%13.7K after10b5-1
May 2, 2024 (view filing)May 11 dayCoward D ScottDirectorSSale−67$60.15−$4.03K−0.1%44.6K after10b5-1
May 2, 2024 (view filing)May 11 dayCunningham EverettChief Commercial OfficerSSale−136$60.15−$8.18K−0.3%47.0K after10b5-1
May 2, 2024 (view filing)May 11 dayHerriott JamesSVP, General Counsel & SecSSale−30$60.15−$1.80K−0.3%9.87K after10b5-1
May 2, 2024 (view filing)May 11 dayConroy Kevin TPresident and CEOSSale−1.16K$60.15−$69.5K−0.1%1.16M after10b5-1
May 2, 2024 (view filing)May 11 dayOrville Jacob AGeneral Manager, ScreeningSSale−102$60.15−$6.14K−0.7%14.4K after10b5-1
May 2, 2024 (view filing)May 11 dayBaranick BrianEVP, GM., Precision OncologySSale−110$60.15−$6.62K−0.8%13.3K after10b5-1
May 2, 2024 (view filing)May 11 dayCondella SarahEVP, Human ResourcesSSale−102$60.15−$6.14K−0.1%72.6K after10b5-1
May 2, 2024 (view filing)May 11 dayElliott Jeffrey ThomasChief Financial OfficerSSale−136$60.15−$8.18K−1.1%11.8K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysCondella SarahEVP, Human ResourcesSSale−2.00K$70.00−$140.0K−2.7%71.8K after10b5-1
Apr 3, 2024 (view filing)Apr 21 dayBaranick BrianEVP, GM., Precision OncologySSale−924$79.43−$73.4K−6.6%13.2K after10b5-1
Apr 1, 2024 (view filing)Mar 284 daysCondella SarahEVP, Human ResourcesSSale−2.00K$70.00−$140.0K−2.6%73.8K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysOrville Jacob AGeneral Manager, ScreeningSSale−2.15K$59.32−$127.8K−13.1%14.3K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysLevangie Daniel JDirectorSSale−5.00K$57.50−$287.5K−17.9%23.0K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysHerriott JamesGeneral CounselSSale−862$59.32−$51.1K−8.6%9.13K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysElliott Jeffrey ThomasChief Financial OfficerSSale−2.41K$59.32−$143.1K−18.1%10.9K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysDoyle James EdwardDirectorSSale−2.00K$57.50−$115.0K−3.8%50.1K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysCunningham EverettChief Commercial OfficerSSale−2.41K$59.32−$143.1K−5.0%46.2K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysConroy Kevin TPresident and CEOSSale−8.27K$59.32−$490.6K−0.6%1.30M after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysCondella SarahEVP, Human ResourcesSSale−1.72K$59.32−$102.3K−2.2%75.8K after10b5-1
Mar 4, 2024 (view filing)Mar 13 daysBaranick BrianGen. Mgr., Precision OncologySSale−2.32K$59.32−$137.8K−14.1%14.1K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayOrville Jacob AGeneral Manager, ScreeningSSale−1.88K$56.89−$106.9K−13.8%11.8K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayHerriott JamesGeneral CounselSSale−784$56.89−$44.6K−8.8%8.10K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayCunningham EverettChief Commercial OfficerSSale−3.65K$56.89−$207.5K−7.8%43.3K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayElliott Jeffrey ThomasChief Financial OfficerSSale−2.71K$56.89−$154.2K−25.2%8.05K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayConroy Kevin TPresident and CEOSSale−6.26K$56.89−$356.3K−0.5%1.29M after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayCondella SarahEVP, Human ResourcesSSale−1.88K$56.89−$107.0K−2.5%73.7K after10b5-1
Feb 28, 2024 (view filing)Feb 271 dayBaranick BrianGen. Mgr., Precision OncologySSale−2.03K$56.89−$115.3K−14.8%11.7K after10b5-1
Feb 26, 2024 (view filing)Feb 233 daysCondella SarahEVP, Human ResourcesSSale−1.02K$59.72−$61.0K−1.4%71.7K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayOrville Jacob AGeneral Manager, ScreeningSSale−1.01K$59.78−$60.6K−9.5%9.68K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayHerriott JamesGeneral CounselSSale−291$59.78−$17.4K−3.9%7.23K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayElliott Jeffrey ThomasChief Financial OfficerSSale−1.35K$59.78−$80.8K−21.1%5.06K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayCunningham EverettChief Commercial OfficerSSale−1.35K$59.78−$80.7K−3.3%39.3K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayCoward D ScottDirectorSSale−663$59.78−$39.6K−1.5%44.5K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayConroy Kevin TPresident and CEOSSale−11.6K$59.78−$691.4K−0.9%1.24M after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayCondella SarahEVP, Human ResourcesSSale−1.01K$59.78−$60.6K−1.4%72.7K after10b5-1
Feb 23, 2024 (view filing)Feb 221 dayBaranick BrianGen. Mgr., Precision OncologySSale−1.09K$59.78−$65.3K−10.1%9.77K after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayOrville Jacob AGeneral Manager, ScreeningSSale−1.08K$61.50−$66.3K−11.1%8.66K after10b5-1
Feb 22, 2024 (view filing)Feb 211 dayHerriott JamesGeneral CounselSSale−415$61.50−$25.5K−5.6%6.94K after10b5-1